Cloned T cells from a recent onset IDDM patient reactive with insulin B- chain

Journal of Autoimmunity

Volumn 11, Issue 2, 1998, Pages 169-175

  Schloot, Nanette C ^a   Willemen, Sabine ^b   Duinkerken, Gaby ^b   De Vries, René R P ^b   Roep, Bart O ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Autoimmunity; Insulin; T lymphocyte; T cell clone

Indexed keywords

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031746774     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0183     Document Type: Article

References (41)

1. Atkinson M.A., Maclaren N.K. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436
2. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. 1983. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 222: 1337-1339
3. Riley W.J., Atkinson M.A., Maclaren N.K. 1988. Insulin autoantibodies in pre-diabetes. Adv. Exp. Med. Biol. 246: 45-51
4. Roep B.O., Kallan A.A., Hazenbos W.L., Bruining G.J., Bailyes E.M., Arden S.D., Hutton J.C., De Vries R.R.P. 1991. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337: 1439-1441
5. Roep B.O., Kallan A.A., Duinkerken G., Arden S.D., Hutton J.C., Bruining G.J., de Vries R.R. 1995. T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM.. Diabetes 44: 278-283
6. Bottazzo G.F., Florin-Christensen A., Doniach D. 1974. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii: 1279-1282
7. Payton M.A., Hawkes C.J., Christie M.R. 1995. Relationship of the 37,000- and 40,000-Mr Tryptic Fragment of Islet Antigens in Insulin-dependent Diabetes to the Protein Tyrosine Phosphatase-like Molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511
8. Durinovic-Bello I., Hummel M., Ziegler A.G. 1996. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45: 795-800
9. Atkinson M.A., Maclaren N.K., Scharp D.W., Lacy P.E., Riley W.J. 1990. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357-1360
10. Wegmann D.R., Shehadeh N., Lafferty K.J., Norbury-Glaser M., Gill R.G., Daniel D. 1993. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. J. Autoimmun. 6: 517-527
11. Haskins K., Portas M., Bradley B., Wegmann D., Lafferty K.1988. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37: 1444-1448
12. Schloot N.C., Daniel D., Norbury-Glaser M., Wegmann D.R. 1996.Peripheral T cell clones from NOD mice specific for GAD65 peptides: Lack of islet responsiveness or diabetogenicity. J. Autoimmun. 9: 357-363
13. Wegmann D.R., Norbury-Glaser M., Daniel D. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24: 1853-1857
14. Daniel D., Gill R.G., Schloot N., Wegmann D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062
15. Atkinson M.A., Maclaren N.K., Luchetta R. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933-937
16. Daniel D., Wegmann D.R. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide b-(9-23). Proc. Natl. Acad. Sci. USA 93: 956-960
17. Bergerot I., Ploix C., Petersen J., Moulin V., Rask C., Fabien N., Lindblad M., Mayer A., Czerkinsky C., Holmgren J., Thivolet C. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94: 4610-4614
18. Keller R.J., Eisenbarth G.S, Jackson R.A. 1993. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341: 927-928
19. Schloot N., Eisenbarth G.S. 1995. Isohormonal therapy of endocrine autoimmunity. Immunology Today 16: 289-294
20. Polanski M., Melican N.S., Zhang J., Weiner H.L. 1997. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun 10: 339-349
21. Schloot N.C., Roep B.O. 1997. Islet-antigen specific T-cell clones in autoimmune diabetes: From mice to men. Diabetes. Metab. Rev. 13: 127-138
22. Miller G.G., Pollack M.S., Nell L.J., Thomas J.W. 1987. Insulin-specific human T cells. J. Immunol. 139: 3622-3629
23. Naquet G.G., Ellis J., Tibensky D., Kenshole A., Singh B., Hodges R., Delovitch T.L. 1988. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol. 140: 2569-2578
24. Ito Y., Nieda M., Uchigata Y., Nishimura M., Tokunaga K., Kuwata S., Obata F., Tadokoro K., Hirata Y., Omori Y., Juji T. 1993. Recognition of human insulin in the context of HLA- DRB1*0406 products by T-cells of insulin autoimmune syndrome patients and healthy donors. J. Immunol. 151: 5770-5776
25. Schloot N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Wang T., Eisenbarth G.S. 1997. Altered immune responses to insulin in newly diagnosed versus insulin treated diabetic patients and healthy control subjects. Diabetologia 40: 564-572
26. William A.J.K., Bingley P.J., Bonifacio E., Palmer J.P., Gale E.A.M. 1997. A novel microassay for insulin autoantibodies. J. Autoimmun. 10: 473-478
27. de Koster H.S., Amons R., Benckhuijsen W.E., Feijlbrief M., Schellekens G.A., Drijfhout J.W. 1995. The use of dedicated peptide libraries permits the discovery of high affinity binding peptides. J. Immunol. Methods 187: 179-188
28. Moody A.J., Hejnaes K.R., Marshall M.O., Larsen F.S., Boel E., Svendsen I., Mortensen E., Dyrberg T. 1995. Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in sf9 insect cells. Diabetologia 38: 14-23
29. Neophytou P.I., Roep B.O., Arden S.D., Muir E.M., Duinkerken G., Kallan A.A., De Vries R.R.P., Hutton J.C. 1996. T-cell epitope analysis using subtracted expression libraries (TEASEL). Application to a 38kDa autoantigen recognised by T-cells from an insulin-dependent diabetic patient. Proc. Natl. Acad. Sci. USA 93: 2014-2018
30. Kallan A.A., Roep B.O., Arden S.D., Hutton J.C., De Vries R.R.P. 1995. Beta-cell reactive T-cell clones from type 1 diabetes patients are not beta cell specific and recognize multiple antigens. J. Autoimmun. 8: 877-899
31. Douglas-Petersen L., Duinkerken G., Bruining G.J., van Lier R.A.W., De Vries R.R.P., Roep B.O. 1996. Increased numbers of in vivo activated T cells in patients with recent onset insulins-dependent diabetes mellitus. J. Autoimmun. 9: 731-737
32. Geluk A., Meijgaarden K.E., Ottenhoff T.H.M. 1997. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype. Immunology 90: 370-375
33. Nell L.J., Virta V.J., Thomas J.W. 1985. Recognition of human insulin in vitro by T cells from subjects treated with animal insulins. J. Clin. Invest. 76: 2070-2077
34. Zekzer D., Wong F.S., Wen L., Altieri M., Gurlo T., von Grafenstein H., Sherwin, R.S. 1997. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the non-obese diabetic mouse. Diabetes 46: 1124-1132
35. Tompkins S.M., Moore J.C., Jensen P.E. 1996. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183: 857-866
36. MacCuish A.C., Jordan J., Campbell C.J., Duncan L.P.J., Irvine W.J. 1975. Cell mediated immunity in diabetes mellitus: lymphocyte transformation by insulin and insulin fragments in insulin treated and newly diagnosed diabetics. Diabetes 24: 36-43
37. Miller G.G., Hoy J.F., Thomas J.W. 1989. Insulin B chain functions as an effective competitor of antigen presentation via peptide homologies present in the thymus. J. Exp. Med. 169: 2251-2256
38. Uchigata Y., Chino J., Katoh H., Uchiyama T., Tokunaga K., Omori Y. 1997. Probable recognition of human insulin in the context of HLA-DRB1*0406 molecule by Vβ8 T cells. Diabetologia 40, suppl. 1: A88
39. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmitz G., Meinl E., Hummel M., Ziegler A.G., Wank R., Schendel D.J. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99: 2405-2415
40. Bach J.M., Otto H., Nepom G.T., Jung G., Cohen H., Timsit J., Boitard C., van Endert P.M. 1997. High affinity presentation of an autoantigenic peptide in Type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J Autoimmun. 10: 375-386
41. Bergerot I., Fabien N., Maguer V., Thivolet C. 1994. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7: 655-663